SCHEMBL23840604

SCHEMBL23840604

C=C(Nc1cnc(OC)c(S(=O)(=O)Nc2ccc(Cl)cc2)c1)c1ccccc1C(=O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA1 P56199 1/20 0.45
IDH1 O75874 10/20 0.44
PGR P06401 1/20 0.41
ALPL P05186 1/20 0.41
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
MAPT P10636 2/20 0.40
AVPR2 P30518 1/20 0.40
GPR27 Q9NS67 1/20 0.40
GAA P10253 1/20 0.40
USP2 O75604 1/20 0.40
PIK3CD O00329 1/20 0.40
PIK3R1 P27986 1/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CB P42338 1/20 0.40
PIK3CG P48736 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MITF O75030 1/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23840606 0.91 ITGA1 (0.43) ITGA1IDH1PGRALPLMEN1
SCHEMBL23833480 0.91 GPR27 (0.48) ITGA1IDH1ALPLMEN1KMT2A
SCHEMBL30151063 0.91 GPR27 (0.48) ITGA1IDH1ALPLMEN1KMT2A
SCHEMBL23833408 0.85 MAPT (0.44) ITGA1IDH1ALPLMEN1KMT2A
SCHEMBL30151035 0.85 MAPT (0.44) ITGA1IDH1ALPLMEN1KMT2A
SCHEMBL23840396 0.79 PIK3CD (0.43) IDH1ALPLMEN1KMT2AMAPT
SCHEMBL23840609 0.79 SMN1; SMN2 (0.40) IDH1MEN1KMT2AMAPTGAA
SCHEMBL23840316 0.78 IDH1 (0.41) ITGA1IDH1ALPLMEN1KMT2A
SCHEMBL23840608 0.78 IDH1 (0.42) IDH1ALPLMEN1KMT2AMAPT
SCHEMBL23840486 0.77 IDH1 (0.40) IDH1ALPLMEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021188907-A1 PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF AMATHUS THERAPEUTICS, INC. (US) 2021-09-23 WO disclosed